- Home
- BDTX vs DCF Comparison
BDTX vs DCF Comparison
Compare BDTX & DCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- DCF
- Stock Information
- Founded
- BDTX 2014
- DCF 2014
- Country
- BDTX United States
- DCF United States
- Employees
- BDTX N/A
- DCF N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- DCF Finance/Investors Services
- Sector
- BDTX Health Care
- DCF Finance
- Exchange
- BDTX Nasdaq
- DCF Nasdaq
- Market Cap
- BDTX 161.6M
- DCF 137.0M
- IPO Year
- BDTX 2020
- DCF N/A
- Fundamental
- Price
- BDTX $2.62
- DCF $9.24
- Analyst Decision
- BDTX Strong Buy
- DCF
- Analyst Count
- BDTX 4
- DCF 0
- Target Price
- BDTX $15.50
- DCF N/A
- AVG Volume (30 Days)
- BDTX 591.8K
- DCF 33.2K
- Earning Date
- BDTX 11-05-2024
- DCF 01-01-0001
- Dividend Yield
- BDTX N/A
- DCF 5.25%
- EPS Growth
- BDTX N/A
- DCF N/A
- EPS
- BDTX N/A
- DCF N/A
- Revenue
- BDTX N/A
- DCF N/A
- Revenue This Year
- BDTX N/A
- DCF N/A
- Revenue Next Year
- BDTX N/A
- DCF N/A
- P/E Ratio
- BDTX N/A
- DCF N/A
- Revenue Growth
- BDTX N/A
- DCF N/A
- 52 Week Low
- BDTX $2.09
- DCF $7.25
- 52 Week High
- BDTX $7.66
- DCF $8.67
- Technical
- Relative Strength Index (RSI)
- BDTX 31.71
- DCF 58.78
- Support Level
- BDTX $3.16
- DCF $9.19
- Resistance Level
- BDTX $3.44
- DCF $9.25
- Average True Range (ATR)
- BDTX 0.22
- DCF 0.05
- MACD
- BDTX 0.03
- DCF 0.00
- Stochastic Oscillator
- BDTX 0.61
- DCF 92.31
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About DCF BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc.
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date.